pharma · Glioblastoma · Unresectable or metastatic soft tissue sarcoma
Philogen
Philogen S.p.A.
Philogen S.p.A is a pharma organization headquartered in SIENA, IT. Primary therapeutic focus areas include Glioblastoma, Unresectable or metastatic soft tissue sarcoma, Cutaneous Squamous Cell Carcinoma, locally advance
Loc. Bellaria, 35, Sovicille, SIENA 53018, IT HQ
1996 Founded
180 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Loc. Bellaria, 35, Sovicille, SIENA 53018, IT
- Founded
- 1996
- Employees
- 180
- Programs
- 18
- Drugs
- 29
- Patents
- 0
PH-L19TNFDOX2-03/16
Phase 3 · small molecule · Unresectable or metastatic soft tissue sarcoma
PH-L19TNFDOX2-03/16 for Unresectable or metastatic soft tissue sarcoma is a Phase 3 program (small_molecule) at Philogen S.p.A. with 1 ClinicalTrials.gov record(s).
Internal code PH-L19TNFDOX2-03/16
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Philogen S.p.A.
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Unresectable or metastatic soft tissue sarcoma
- Status
- active
- Trials
- 1